| pre-PERT (PP) (n = 215) | PERT-alerted (PA) (n = 107) | Non-PERT alerted (NPA) (n = 185) | P value |
---|---|---|---|---|
none, No. (%) | 21 (10) | 7 (7) | 14 (8) | 0.581 |
Apixaban, No. (%) | 76 (35) | 71 (66) | 105 (57) | < 0.001 |
Dabigatran, No. (%) | 0 | 2 (2) | 5 (3) | 0.032 |
Edoxaban, No. (%) | 0 | 1 (1) | 2 (1) | 0.322 |
Enoxaparin, No. (%) | 34 (16) | 16 (16) | 28 (15) | 0.987 |
Enoxaparin+Warfarin, No. (%) | 0 | 6 (6) | 0 | < 0.001 |
Fonadaparinux | 1 (1) | 0 | 1 (1) | 1.000 |
Rivaroxaban, No. (%) | 37 (17) | 2 (2) | 12 (7) | < 0.001 |
Warfarin, No. (%) | 48 (22) | 2 (2) | 18 (10) | < 0.001 |